Though not qualified to be a typical exosomal biomarker, a remarkable absence of TP53 gDNA in cancer exosomes–derived from GBM–is attributed to the loss of heterozygosity of chromosome 17 at position p13.1. This evidence concerns the gene TP53 and cancer.